DEFB110
gene geneOn this page
Also known as DEFB-10DEFB-11DEFB111
Summary
DEFB110 (defensin beta 110, HGNC:18091) is a protein-coding gene on chromosome 6p12.3, encoding Beta-defensin 110 (Q30KQ9). Has antibacterial activity.
Defensins form a family of antimicrobial and cytotoxic peptides made by neutrophils. Defensins are short, processed peptide molecules that are classified by structure into three groups: alpha-defensins, beta-defensins and theta-defensins. All beta-defensin genes are densely clustered in four to five syntenic chromosomal regions. Two transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 245913 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 13 total
- MANE Select transcript:
NM_001037497
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18091 |
| Approved symbol | DEFB110 |
| Name | defensin beta 110 |
| Location | 6p12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DEFB-10, DEFB-11, DEFB111 |
| Ensembl gene | ENSG00000203970 |
| Ensembl biotype | protein_coding |
| Entrez | 245913 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000371148, ENST00000393660
RefSeq mRNA: 2 — MANE Select: NM_001037497
NM_001037497, NM_001037728
CCDS: CCDS34475, CCDS43473
Canonical transcript exons
ENST00000371148 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001454462 | 50018843 | 50019125 |
| ENSE00001454463 | 50021881 | 50021994 |
Expression profiles
Bgee: expression breadth broad, 35 present calls, max score 92.91.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0233 / max 40.6063, expressed in 1 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 73939 | 0.0233 | 1 |
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.16 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| monocyte | CL:0000576 | 32.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| leukocyte | CL:0000738 | 31.79 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| urinary bladder | UBERON:0001255 | 28.73 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| calcaneal tendon | UBERON:0003701 | 27.22 | silver quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| ectocervix | UBERON:0012249 | 24.31 | gold quality |
| pancreas | UBERON:0001264 | 24.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- The encoded protein is thought to have antimicrobial activity. (PMID:16033865)
- Antimicrobial activity and structure of a consensus human beta-defensin and its comparison to a novel putative hBD10. (PMID:31325337)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb41 | ENSMUSG00000067773 |
| rattus_norvegicus | Defb17 | ENSRNOG00000079073 |
Protein
Protein identifiers
Beta-defensin 110 — Q30KQ9 (reviewed: Q30KQ9)
Alternative names: Beta-defensin 10, Beta-defensin 11, Beta-defensin 111, Defensin, beta 110, Defensin, beta 111
All UniProt accessions (1): Q30KQ9
UniProt curated annotations — full annotation on UniProt →
Function. Has antibacterial activity.
Subcellular location. Secreted.
Similarity. Belongs to the beta-defensin family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q30KQ9-1 | 1 | yes |
| Q30KQ9-2 | 2 |
RefSeq proteins (2): NP_001032586, NP_001032817 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025933 | Beta_defensin_dom | Domain |
Pfam: PF13841
UniProt features (6 total): disulfide bond 3, signal peptide 1, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q30KQ9-F1 | 80.43 | 0.22 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 35–63, 42–56, 46–64
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 32 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_CELL_CHEMOTAXIS, GOBP_TAXIS, chr6p12, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, GOMF_SIGNALING_RECEPTOR_BINDING, GOBP_POSITIVE_CHEMOTAXIS, GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP, GOMF_CHEMOATTRACTANT_ACTIVITY, GOMF_CCR_CHEMOKINE_RECEPTOR_BINDING, GOBP_RESPONSE_TO_BACTERIUM, GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY
GO Biological Process (5): defense response to bacterium (GO:0042742), innate immune response (GO:0045087), cell chemotaxis (GO:0060326), defense response (GO:0006952), positive chemotaxis (GO:0050918)
GO Molecular Function (2): CCR6 chemokine receptor binding (GO:0031731), chemoattractant activity (GO:0042056)
GO Cellular Component (2): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chemotaxis | 2 |
| defense response | 1 |
| response to bacterium | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| cell migration | 1 |
| cellular response to chemical stimulus | 1 |
| response to stress | 1 |
| CCR chemokine receptor binding | 1 |
| receptor ligand activity | 1 |
| positive chemotaxis | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
258 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DEFB110 | DEFB113 | Q30KQ7 | 727 |
| DEFB110 | DEFB107A | Q8IZN7 | 697 |
| DEFB110 | DEFB127 | Q9H1M4 | 648 |
| DEFB110 | DEFB115 | Q30KQ5 | 574 |
| DEFB110 | DEFB105A | Q8NG35 | 570 |
| DEFB110 | DEFB129 | Q9H1M3 | 540 |
| DEFB110 | DEFB114 | Q30KQ6 | 518 |
| DEFB110 | DEFB112 | Q30KQ8 | 517 |
| DEFB110 | DEFB134 | Q4QY38 | 514 |
| DEFB110 | DEFB126 | Q9BYW3 | 506 |
| DEFB110 | DEFB132 | Q7Z7B7 | 504 |
| DEFB110 | DEFB106A | Q8N104 | 479 |
| DEFB110 | DEFB128 | Q7Z7B8 | 477 |
| DEFB110 | DEFB103A | P81534 | 472 |
| DEFB110 | DEFB131A | P59861 | 471 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DEFB110 | NME2P1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (14): TMEM67 (Affinity Capture-MS), ARMC8 (Affinity Capture-MS), ADAM11 (Affinity Capture-MS), LRP11 (Affinity Capture-MS), CTBS (Affinity Capture-MS), FUT11 (Affinity Capture-MS), NME2P1 (Affinity Capture-MS), UBR2 (Affinity Capture-MS), PICK1 (Affinity Capture-MS), CACNA2D2 (Affinity Capture-MS), HLA-DQA1 (Affinity Capture-MS), HSPA5 (Affinity Capture-MS), GRN (Affinity Capture-MS), CAMKMT (Affinity Capture-MS)
ESM2 similar proteins: A0A096LNP1, A4H206, A4H207, A4H208, A4H209, A4H212, A4H213, P0C8A5, P0C8B0, P0DP73, P0DP74, P59861, P82020, P82172, Q30KJ3, Q30KJ5, Q30KJ6, Q30KJ8, Q30KJ9, Q30KK8, Q30KL4, Q30KL6, Q30KM9, Q30KP5, Q30KP6, Q30KP8, Q30KQ1, Q30KQ6, Q30KQ7, Q30KQ9, Q32ZF3, Q32ZF7, Q32ZG3, Q32ZH4, Q32ZH5, Q32ZH6, Q32ZI1, Q32ZI2, Q4QY38, Q6QLQ7
Diamond homologs: A8MXU0, Q30KL6, Q30KQ9, Q5IAA6, Q8NET1, Q30KL5, Q30KP6, Q30KQ8, Q30KU3, Q32ZH5, A4H213, Q30KJ6, Q30KP5, Q30KQ1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
13 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 13 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
124 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:50019126:C:CC | acceptor_gain | 0.9100 |
| 6:50019123:TGGC:T | acceptor_loss | 0.8700 |
| 6:50019125:GCTG:G | acceptor_loss | 0.8700 |
| 6:50019126:C:CA | acceptor_loss | 0.8700 |
| 6:50019127:T:TC | acceptor_loss | 0.8700 |
| 6:50021875:TATTA:T | donor_loss | 0.8500 |
| 6:50021876:ATTAC:A | donor_loss | 0.8500 |
| 6:50021877:TTACC:T | donor_loss | 0.8500 |
| 6:50021878:TACCT:T | donor_loss | 0.8500 |
| 6:50021879:A:C | donor_loss | 0.8500 |
| 6:50021880:C:G | donor_loss | 0.8500 |
| 6:50019122:TTGG:T | acceptor_gain | 0.8400 |
| 6:50019123:TGG:T | acceptor_gain | 0.8400 |
| 6:50019121:TTTGG:T | acceptor_gain | 0.8300 |
| 6:50020529:T:TA | donor_gain | 0.8100 |
| 6:50019124:GG:G | acceptor_gain | 0.8000 |
| 6:50021881:C:A | donor_loss | 0.7900 |
| 6:50021874:ATATT:A | donor_loss | 0.7600 |
| 6:50019151:ATTAG:A | acceptor_loss | 0.7200 |
| 6:50019142:A:C | acceptor_loss | 0.7000 |
| 6:50019149:AAATT:A | acceptor_loss | 0.7000 |
| 6:50019150:AATTA:A | acceptor_loss | 0.7000 |
| 6:50019152:T:TC | acceptor_loss | 0.7000 |
| 6:50018980:CTG:C | acceptor_gain | 0.6900 |
| 6:50019148:AAAAT:A | acceptor_loss | 0.6500 |
| 6:50019153:TAG:T | acceptor_loss | 0.6200 |
| 6:50019154:A:T | acceptor_loss | 0.5500 |
| 6:50019102:C:CT | acceptor_loss | 0.5200 |
| 6:50019131:A:C | acceptor_loss | 0.5000 |
| 6:50018989:G:GA | acceptor_gain | 0.4600 |
AlphaMissense
447 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:50019056:C:G | C42S | 0.949 |
| 6:50019057:A:T | C42S | 0.949 |
| 6:50019077:C:G | C35S | 0.949 |
| 6:50019078:A:T | C35S | 0.949 |
| 6:50019013:G:C | C56W | 0.930 |
| 6:50019044:C:G | C46S | 0.928 |
| 6:50019045:A:T | C46S | 0.928 |
| 6:50018992:G:C | C63W | 0.920 |
| 6:50018989:G:C | C64W | 0.919 |
| 6:50018993:C:G | C63S | 0.918 |
| 6:50018994:A:T | C63S | 0.918 |
| 6:50019014:C:G | C56S | 0.916 |
| 6:50019015:A:T | C56S | 0.916 |
| 6:50019076:G:C | C35W | 0.915 |
| 6:50018990:C:G | C64S | 0.912 |
| 6:50018991:A:T | C64S | 0.912 |
| 6:50019014:C:T | C56Y | 0.906 |
| 6:50019045:A:G | C46R | 0.897 |
| 6:50019055:A:C | C42W | 0.897 |
| 6:50019057:A:G | C42R | 0.896 |
| 6:50019078:A:G | C35R | 0.896 |
| 6:50019015:A:G | C56R | 0.894 |
| 6:50019043:A:C | C46W | 0.887 |
| 6:50019062:C:T | G40D | 0.880 |
| 6:50019077:C:T | C35Y | 0.880 |
| 6:50019063:C:A | G40C | 0.878 |
| 6:50018994:A:G | C63R | 0.872 |
| 6:50019014:C:A | C56F | 0.872 |
| 6:50019077:C:A | C35F | 0.866 |
| 6:50019056:C:T | C42Y | 0.865 |
dbSNP variants (sampled 300 via entrez): RS1000331450 (6:50022509 T>C,G), RS1000434797 (6:50011819 G>T), RS1000811934 (6:50023575 T>C), RS1000843558 (6:50019610 T>C), RS1001073302 (6:50021005 T>C), RS1001129517 (6:50020492 T>C), RS1001181618 (6:50020858 GTTA>G), RS1001353343 (6:50014050 T>C), RS1001484713 (6:50010132 T>C), RS1001516800 (6:50015962 G>T), RS1001822509 (6:50014827 C>T), RS1001853577 (6:50014398 A>C), RS1001923717 (6:50009000 A>C,G), RS1002340929 (6:50019787 C>A,T), RS1002439941 (6:50009253 G>A,C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| coumarin | increases phosphorylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.